Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Greenrise Global Brands Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CA$0.002 |
52 Week High | CA$0.022 |
52 Week Low | CA$0.001 |
Beta | 1.0 |
11 Month Change | 100.00% |
3 Month Change | 0% |
1 Year Change | -80.00% |
33 Year Change | -99.20% |
5 Year Change | -99.06% |
Change since IPO | -97.59% |
Recent News & Updates
Recent updates
Shareholder Returns
C4T | DE Capital Markets | DE Market | |
---|---|---|---|
7D | 0% | 1.6% | 4.5% |
1Y | -80.0% | 29.0% | 13.4% |
Return vs Industry: C4T underperformed the German Capital Markets industry which returned 28.7% over the past year.
Return vs Market: C4T underperformed the German Market which returned 12.6% over the past year.
Price Volatility
C4T volatility | |
---|---|
C4T Average Weekly Movement | 344.5% |
Capital Markets Industry Average Movement | 4.8% |
Market Average Movement | 5.0% |
10% most volatile stocks in DE Market | 11.6% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: C4T's share price has been volatile over the past 3 months.
Volatility Over Time: C4T's weekly volatility has increased from 295% to 344% over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | n/a | Tom Kusumoto | greenriseglobal.com |
Greenrise Global Brands Inc. does not have significant operations. Previously, it was engaged in the supply of medical cannabis products. The company was formerly known as AMP Alternative Medical Products Inc. and changed its name to Greenrise Global Brands Inc. in November 2021.
Greenrise Global Brands Inc. Fundamentals Summary
C4T fundamental statistics | |
---|---|
Market cap | €312.97k |
Earnings (TTM) | -€174.10k |
Revenue (TTM) | n/a |
0.0x
P/S Ratio-1.8x
P/E RatioIs C4T overvalued?
See Fair Value and valuation analysisEarnings & Revenue
C4T income statement (TTM) | |
---|---|
Revenue | €0 |
Cost of Revenue | €0 |
Gross Profit | €0 |
Other Expenses | €174.10k |
Earnings | -€174.10k |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.0037 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | -110.6% |
How did C4T perform over the long term?
See historical performance and comparison